These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 10192823)

  • 21. In vivo vulnerability to competition by endogenous dopamine: comparison of the D2 receptor agonist radiotracer (-)-N-[11C]propyl-norapomorphine ([11C]NPA) with the D2 receptor antagonist radiotracer [11C]-raclopride.
    Narendran R; Hwang DR; Slifstein M; Talbot PS; Erritzoe D; Huang Y; Cooper TB; Martinez D; Kegeles LS; Abi-Dargham A; Laruelle M
    Synapse; 2004 Jun; 52(3):188-208. PubMed ID: 15065219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of reserpine-induced depletion of synaptic dopamine on [11C]raclopride binding to D2-dopamine receptors in the monkey brain.
    Ginovart N; Farde L; Halldin C; Swahn CG
    Synapse; 1997 Apr; 25(4):321-5. PubMed ID: 9097390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreasing amphetamine-induced dopamine release by acute phenylalanine/tyrosine depletion: A PET/[11C]raclopride study in healthy men.
    Leyton M; Dagher A; Boileau I; Casey K; Baker GB; Diksic M; Gunn R; Young SN; Benkelfat C
    Neuropsychopharmacology; 2004 Feb; 29(2):427-32. PubMed ID: 14583741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence for striatal dopamine release during a video game.
    Koepp MJ; Gunn RN; Lawrence AD; Cunningham VJ; Dagher A; Jones T; Brooks DJ; Bench CJ; Grasby PM
    Nature; 1998 May; 393(6682):266-8. PubMed ID: 9607763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Striatal and extrastriatal dopamine D2 receptor occupancy by a novel antipsychotic, blonanserin: a PET study with [11C]raclopride and [11C]FLB 457 in schizophrenia.
    Tateno A; Arakawa R; Okumura M; Fukuta H; Honjo K; Ishihara K; Nakamura H; Kumita S; Okubo Y
    J Clin Psychopharmacol; 2013 Apr; 33(2):162-9. PubMed ID: 23422369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alcohol dependence is associated with blunted dopamine transmission in the ventral striatum.
    Martinez D; Gil R; Slifstein M; Hwang DR; Huang Y; Perez A; Kegeles L; Talbot P; Evans S; Krystal J; Laruelle M; Abi-Dargham A
    Biol Psychiatry; 2005 Nov; 58(10):779-86. PubMed ID: 16018986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dose dependent occupancy of central dopamine D2 receptors by the novel neuroleptic CP-88,059-01: a study using positron emission tomography and 11C-raclopride.
    Bench CJ; Lammertsma AA; Dolan RJ; Grasby PM; Warrington SJ; Gunn K; Cuddigan M; Turton DJ; Osman S; Frackowiak RS
    Psychopharmacology (Berl); 1993; 112(2-3):308-14. PubMed ID: 7871035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of central cholinergic blockade on striatal dopamine release measured with positron emission tomography in normal human subjects.
    Dewey SL; Smith GS; Logan J; Brodie JD; Simkowitz P; MacGregor RR; Fowler JS; Volkow ND; Wolf AP
    Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11816-20. PubMed ID: 8265632
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glutamate modulation of dopamine measured in vivo with positron emission tomography (PET) and 11C-raclopride in normal human subjects.
    Smith GS; Schloesser R; Brodie JD; Dewey SL; Logan J; Vitkun SA; Simkowitz P; Hurley A; Cooper T; Volkow ND; Cancro R
    Neuropsychopharmacology; 1998 Jan; 18(1):18-25. PubMed ID: 9408915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dopamine release in response to a psychological stress in humans and its relationship to early life maternal care: a positron emission tomography study using [11C]raclopride.
    Pruessner JC; Champagne F; Meaney MJ; Dagher A
    J Neurosci; 2004 Mar; 24(11):2825-31. PubMed ID: 15028776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of sensory stimulus on striatal dopamine release in humans and cats: a [(11)C]raclopride PET study.
    Thobois S; Hassoun W; Ginovart N; Garcia-Larrea L; Le Cavorsin M; Guillouet S; Bonnefoi F; Costes N; Lavenne F; Broussolle E; Leviel V
    Neurosci Lett; 2004 Sep; 368(1):46-51. PubMed ID: 15342132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of methods for analysis of clinical [11C]raclopride studies.
    Lammertsma AA; Bench CJ; Hume SP; Osman S; Gunn K; Brooks DJ; Frackowiak RS
    J Cereb Blood Flow Metab; 1996 Jan; 16(1):42-52. PubMed ID: 8530554
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic subthalamic nucleus stimulation and striatal D2 dopamine receptors in Parkinson's disease--A [(11)C]-raclopride PET study.
    Thobois S; Fraix V; Savasta M; Costes N; Pollak P; Mertens P; Koudsie A; Le Bars D; Benabid AL; Broussolle E
    J Neurol; 2003 Oct; 250(10):1219-23. PubMed ID: 14586606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Variability in D2-dopamine receptor density and affinity: a PET study with [11C]raclopride in man.
    Farde L; Hall H; Pauli S; Halldin C
    Synapse; 1995 Jul; 20(3):200-8. PubMed ID: 7570351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of atypical antipsychotic drug treatment on amphetamine-induced striatal dopamine release in patients with psychotic disorders.
    Breier A; Su TP; Malhotra AK; Elman I; Adler CM; Weisenfeld NI; Pickar D
    Neuropsychopharmacology; 1999 Apr; 20(4):340-5. PubMed ID: 10088134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulating the rate and rhythmicity of perceptual rivalry alternations with the mixed 5-HT2A and 5-HT1A agonist psilocybin.
    Carter OL; Pettigrew JD; Hasler F; Wallis GM; Liu GB; Hell D; Vollenweider FX
    Neuropsychopharmacology; 2005 Jun; 30(6):1154-62. PubMed ID: 15688092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ketamine does not decrease striatal dopamine D2 receptor binding in man.
    Aalto S; Hirvonen J; Kajander J; Scheinin H; Någren K; Vilkman H; Gustafsson L; Syvälahti E; Hietala J
    Psychopharmacology (Berl); 2002 Dec; 164(4):401-6. PubMed ID: 12457270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential modulation of dopamine D1-receptor binding and mRNA expression in the basal ganglia by the D1-receptor antagonist, SCH-23390.
    Yu J; Coirini H; Källström L; Wiesel FA; Johnson AE
    Synapse; 1998 Sep; 30(1):38-48. PubMed ID: 9704879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alcohol promotes dopamine release in the human nucleus accumbens.
    Boileau I; Assaad JM; Pihl RO; Benkelfat C; Leyton M; Diksic M; Tremblay RE; Dagher A
    Synapse; 2003 Sep; 49(4):226-31. PubMed ID: 12827641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Measurement of striatal D2 dopamine receptor density and affinity with [11C]-raclopride in vivo: a test-retest analysis.
    Hietala J; Någren K; Lehikoinen P; Ruotsalainen U; Syvälahti E
    J Cereb Blood Flow Metab; 1999 Feb; 19(2):210-7. PubMed ID: 10027776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.